LPYFD-NH2
LPYFD-NH2, a pentapeptide, exerts some inhibitory effect on the aggregation of Aβ(1-42). LPYFD-NH2 can be used for the research of Alzheimer’s disease.
For research use only. We do not sell to patients.
- CAS No.: 700361-48-4
- Formula: C33H44N6O8
- Molecular Weight:652.74
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-P1061
ColivelinNeuroprotectant/STAT3 Activator -
HY-103240
Methoxy-X04Fluorescent Dye -
HY-14602
TramiprosateNeuroprotection Agent -
HY-18292
ARN2966APP Translation Modulator -
HY-103241
Ro 90-7501Amyloid β42 Inhibitor -
HY-13779
(E/Z)-J147Neuroprotective Agent -
HY-19370
FPS-ZM1Amyloid-β Inhibitor -
HY-13027
DAPTγ-secretase Inhibitor -
HY-16659
EHT 1864Rac Family Inhibitor -
HY-P1363A
β-Amyloid (1-42), humanAmyloid β Peptide -
HY-P1363B
β-Amyloid (1-42), human, HFIP-treatedβ-Amyloid (1-42) Peptide -
HY-103242
CRANAD-2Fluorescent Probe
Biological Activity
Description
Chemical Information
-
CAS No. 700361-48-4
-
Molecular Weight 652.74
-
Formula C33H44N6O8
-
Sequence Shortening
LPYFD-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvent & Solubility
In Vitro
H2O
Peptide Solubility and Storage Guidelines:
1. Calculate the length of the peptide.
2. Calculate the overall charge of the entire peptide according to the following table:
| Contents | Assign value | |
|---|---|---|
| Acidic amino acid | Asp (D), Glu (E), and the C-terminal -COOH. | -1 |
| Basic amino acid | Arg (R), Lys (K), His (H), and the N-terminal -NH2 | +1 |
| Neutral amino acid | Gly (G), Ala (A), Leu (L), Ile (I), Val (V), Cys (C), Met (M), Thr (T), Ser (S), Phe (F), Tyr (Y), Trp (W), Pro (P), Asn (N), Gln (Q) | 0 |
3. Recommended solution:
| Overall charge of peptide | Details |
|---|---|
| Negative (<0) |
1. Try to dissolve the peptide in water first. 2. If water fails, add NH4OH (<50 μL). 3. If the peptide still does not dissolve, add DMSO (50-100 μL) to solubilize the peptide. |
| Positive (>0) |
1. Try to dissolve the peptide in water first. 2. If water fails, try dissolving the peptide in a 10%-30% acetic acid solution. 3. If the peptide still does not dissolve, try dissolving the peptide in a small amount of DMSO. |
| Zero (=0) |
1. Try to dissolve the peptide in organic solvent (acetonitrile, methanol, etc.) first. 2. For very hydrophobic peptides, try dissolving the peptide in a small amount of DMSO, and then dilute the solution with water to the desired concentration. |
Protocols
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LPYFD-NH2 Related Classifications
HY-P1060 Related Classifications
Powered by Bioz